4//SEC Filing
Drake Debra A 4
Accession 0000899243-19-013249
CIK 0001563880other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:00 PM ET
Size
13.5 KB
Accession
0000899243-19-013249
Insider Transaction Report
Form 4
Drake Debra A
10% Owner
Transactions
- Conversion
Common Stock
2019-05-09+52,141→ 52,141 total - Conversion
Common Stock
2019-05-09+10,399→ 10,399 total(indirect: By Spouse) - Conversion
Series A Preferred Stock
2019-05-09−58,153→ 0 total→ Common Stock (8,482 underlying) - Conversion
Series A Preferred Stock
2019-05-09−75,000→ 0 total(indirect: By Spouse)→ Common Stock (10,399 underlying) - Conversion
Series C Preferred Stock
2019-05-09−376,023→ 0 total→ Common Stock (43,659 underlying)
Footnotes (2)
- [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001774933
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:00 PM ET
- Size
- 13.5 KB